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Abstract:
Introduction:
Cardiobacterium hominis and Cardiobacterium valvarum are well known, though rare, etiologic agents of infective endocarditis.
Cardiac devices are increasingly implanted.
Case Reports:
Two cases of infective episodes in pacemaker (PM) treated patients with respectively C. hominis and C. valvarum are presented. In
one case blood-culture bottles yielded growth of C. hominis at two episodes with two years apart. At the second episode a vegetation
was recognized at the PM lead and the PM device and lead was removed. In the C. valvarum case, echocardiography revealed a
bicuspid aortic valve with severe regurgitation and a more than 1 cm sized vegetation.
Conclusion:
The cases illustrate the diversity in disease severity by Cardiobacterium species. Careful follow up has to be performed in order not
to overlook a relatively silent relapsing infection.
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INTRODUCTION
The  number  of  patients  receiving  implants  of  cardiac  modulators  is  on  the  rise  and  recipients  had  an  age-
independent  increase  in  comorbidities  relative  to  the  underlying  population,  especially  over  the  past  15  years  [1].
Consequently,  the  challenge  on  possible  infections  related  to  cardiac  devices,  i.e.  pacemakers  and  implantable
cardioverter defribrillators also rises. The infection may include the electrical agent, the ‘tunnel’ in which the electrical
lead is positioned before entry into the blood vessel (known as cardiac device infection [CDI]), or the electrode inside
the blood vessel  (known as CDE) [2].  Cardiobacterium hominis  and Cardiobacterium valvarum  are slow-growing,
fastidious, capnophilic, Gram-negative rod-shaped bacilli represented in the HACEK group of bacteria known to have
the propensity to cause infective endocarditis [3, 4]. HACEK is an acronym for Haemophilus species, Aggregatibacter
actinomycetemcomitans, Cardiobacterium species, Eikenella corrodens and Kingella species. In  the case of C. hominis
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and C. valvarum, infective endocarditis is, with rare exceptions, their only pathological manifestation [2 - 4].
Two cases of infective episodes, in pacemaker (PM) treated patients, with respectively C. hominis and C. valvarum
are reported.
CASE REPORTS
Case Report No. 1
A 66-year-old woman was in May 2011 admitted to a local hospital in Denmark due to fever. She had a DDD-PM
implanted in 1998 because of sick sino-atrial node and was additionally known with asthma, rheumatoid arthritis, and
psoriasis.  In  2007,  she  had  her  generator  exchanged  and  since  experienced  periods  of  fever  and  had  on  several
occasions received antibiotic treatment. On admission she had a temperature of 39,5° C and felt very tired. During the
last 5-6 years, she had lost 40 kg without specific complaints.
Blood samples showed a hemoglobin of 6,0 mmol/l, a C-reactive protein (CRP) of 99 mg/l and a normal leukocyte
count. On suspicion of pyelonephritis, cefuroxime was initiated with good effect and she was subscribed 3 days later.
Two out of 3 blood culture bottles gave growth after 4 days of incubation of what turned out to be C. hominis. The
patient had 2 sets of renewed blood cultures taken, which also after 2 days of incubation yielded growth of what also
turned out to be C. hominis in 2 of 3 blood culture bottles. Echocardiography (transthoracic (TTE) and transesophageal
(TEE))  was  without  vegetations  and  without  significant  valvular  diseases.  The  patient  was  transferred  to  a  highly
specialized  hospital  for  the  evaluation  of  suspected  PM  endocarditis.  Repeated  echocardiography  showed  a  small
vegetation on the pacemaker lead. Precipitating antibodies against Cardiobacterium species were determined by means
of crossed immuno-electrophoresis and showed significantly increased values. The patient again received intravenous
cefuroxime for two weeks and was then changed to intravenous ceftriaxone 2 g per day in two weeks after which she
was afebrile. She was followed weekly for half a year and blood samples showed a CRP of 5-10 mg/l (Fig. 1) which
was acceptable taking the rheumatic disease into consideration. Repeated blood cultures yielded no longer growth of C.
hominis and it was interpreted that the infection had been successfully treated. The patient had in the mean time gained
weight and was afebrile. At follow-up echocardiography, the small vegetation on the PM lead was however still present.
Two years later, she was admitted again with pain related to the lungs. She was diagnosed with pneumonia and treated
with  amoxicillin+clavulanic  acid  500+125  mg  three  times  a  day  and  CRP  declined  from  92  mg/l.  However,  a
simultaneous blood culture grew C. hominis  in one of three bottles and a new TTE revealed a 1.5x1.5 cm pending
vegetation on the electrodes in the tricuspidal ostium. The patient was changed to ceftriaxone 2g once daily and the
DDD-PM including electrodes were removed two days later. The electrodes as well as a tissue biopsy from the PM
pocket  remained  culture  negative.  After  two  weeks  the  patient  had  three  teeths  removed  due  to  chronic  apical
parodontitis and accumulation of leucocytes by leucocyte scintigraphy. In addition, pulmonary embolies were found
further supporting the need for removal of the PM. After 10 days of ceftriaxone treatment, the antibiotic treatment was
changed to amoxicilin 1g four times daily for another three weeks. At the end of antibiotic therapy a new DDD-PM was
installed without complications.
Fig. (1). The figure shows a TEE long axis view of the aortavalve and ascending aorta. The arrow denotes the vegetation on the
bicuspid valve.
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Case Report No. 2
Case  report  no  2:  A  72  year  old  male  was  admitted  to  hospital  due  to  fever,  sudden  partial  loss  of  vision  and
confusion. The patientwas known with ischemic heart disease with previous percutaneous coronary intervention in 2006
and a dual chamber pacemaker due to total atrioventricular block inserted in 2012. During the last 2-month the patient
had experienced intermittent fever as well an unintended weightloss of three kilos. Initial workup included a cerebral
CT scan that showed a subacute infarction of the occipital lobe and a culture negative spinal fluid. Initial antibiotics
were ceftriaxone 2g and ampicillin 2g x 6 daily due to initial suspicion of meningitis. Later one of three blood culture
bottles yielded growth of C. valvarum after three days incubation and treatment was changed to penicillin 3g x 4 daily
and gentamicin 240 mg daily (dosing adjusted by serum-gentamicin concentration determinations). A TEE revealed a
bicuspidaortic valve with severe regurgitation and a large vegetation sized more than 1 cm. The PM leads were without
visible vegetations. Due to severe aortic regurgitation and cerebral embolization, the patient was transferred to a tertiary
hospital for subacute surgical intervention. The thoracic surgeon found severe endocarditis on the bileaflet aortic valve
as well as aortic root dilatation and replaced the valve with a stentless biological valve (Freestyle, Medtronic©). The PM
was left untouched since no vegetations were found on the leads. To avoid nefrotoxicity, gentamicin was changed to
ciprofloxacin and later  moxifloxacin.  Precipitating antibodies against  Cardiobacterium species  were determined by
means of crossed immuno-electrophoresis and showed significantly increased values. The admittance was otherwise
uneventful besides a post-operative pericardial effusion that resolved without intervention. At follow up the patient was
without signs of infection and clinically well.
MICROBIOLOGY
Growth Characteristics of Strains
Bacterial strains were recovered from blood samples using the Bact/Alert system (BioMerieux). One set of blood
cultures  consists  of  two  aerobic  and  one  anaerobic  bottle(s).  In  case  1  all  3  sets  yielding  growth  in  aerobic  blood
cultures (2 out of 3 bottles) became positive after 2-4 days of incubation and in case 2 one of three blood culture bottles
yielded growth after 3 days incubation. For all  strains, microscopy of the blood culture fluid identified non-motile,
Gram-negative, pleomorphic rods. When grown on 5% and 10% horse blood agar as well as on chocolate agar (Statens
Serum Institut,  Copenhagen, Denmark) incubated in ambient air  supplemented with 5% CO2,  the strains grew with
colonies being 1 mm after 24 h incubation and with grey colonies sized 1–2 mm after 48 h incubation. Colonies were
similar, being small, round, opaque, smooth, grey and glistening. There was slight α-haemolysis on blood agar plates.
Strains were facultatively anaerobic.
Identification of Strains
By  conventional  phenotypic  tests  the  strains  were  found  oxidase  positive  and  catalase  negative.  Though  not
obtaining species defining score-values, by MALDI-ToF mass spectrometry the strain from case 1 was most probably
identified as C. hominis  (with a score-value of 1.824, 2 identical hits and a differenece of 0.615 til  next best taxon
match) and the strain from case 2 most probably as C. valvarum (with a score value of 1.517 and a differenece of 0.417
til next best taxon match). Partial 16S rRNA gene sequencing analysis was performed as described previously using the
primers BSF8 and BSR534, which produce a 526 bp product [5].  For the strain in case 1,  a Max score of 808 was
obtained for best taxon match which was C. hominis and more than 25 identical best taxon matches were listed before
next best taxon match occurred which was C. valvarum and a Max score difference of 104 from best to next best taxon
match was noted. For the strain in case 2 a Max score of 917 was obtained for best taxon match which was C. valvarum
and 19 identical best taxon matches were listed before next best taxon match occurred which was C. hominis and a Max
score difference of 239 from best to next best taxon match was noted.
Antibiotic Susceptibility Testing
Antibiotic  susceptibility  testing  was  performed  with  E-test  (BioMerieux).  The  following  Minimal  inhibitory
concentrations (MICs) were obtained for the C. hominis strain: Penicillin G: 0.012 µg/ml, ceftriaxone: 0.023 µg/ml and
for gentamicin: 0.125 µg/ml. For the C. valvarum  strain the following MIC values were found: Penicillin G: 0.016
μg/ml,  ciprofloxacin:  0.008  μg/ml,  moxifloxacin  0.032  μg/ml  and  for  rifampicin  0.032  μg/ml.  The  strains  were
interpreted  as  sensitive  to  the  listed  antibiotics.
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DISCUSSION
Cardiobacterium species are members of the normal upper respiratory flora in humans and may be found rarely on
other  mucosal  surfaces  [3,  4].  Before  2004,  the  genus  consisted  of  only  one  species,  C.  hominis.  However,  a  new
species, C. valvarum, was identified as a novel species within the genus in 2004 [4, 6]. Almost all cases reported have
been infective endocarditis or possible infective endocarditis. Although C. hominis was responsible for only 2 of 1989
cases of endocarditis from 13 published series, it accounted for 14 of 111 cases in case reports of endocarditis due to
unusual organisms [7]. Prosthetic heart valves were infected in 13%, all as late complications of the cardiac surgery. In
approximately half of cases of infective endocarditis cases due to C. hominis, there had been a prior dental procedure or
evidence of gingival infection.
In case 1 the modified Duke criteria for diagnosis of infective endocarditis seems fulfilled as blood cultures gave
growth of a typical causative agent in two different cultures taken at least 12 h apart. However, echocardiographical
findings showed no definite vegetation(s) on the valves or the PM lead during the primary episode in 2011. However,
the vegetation was relatively large at  the second admission two-years  later  where the patient  had signs of  pulmary
embolism and the PM and the electrodes had to  be removed.  That  no growth of  C. hominis  was detected from the
removed PM leads and device can be explained by the initiated antibiotic treatment prior to removal. As no vegetations
were detected at the PM leads in case 2, only antibiotic treatment was chosen and the infective episode was successfully
eradicated  as  long  time  follow up  has  been  without  relapsing  episodes.  A  combination  of  antibiotic  treatment  and
removal of the electrical leads and the device itself will be the most often recommended approach in clear cut episodes
[2]. The cases illustrate the importance of a careful echocardiographic examination giving the possibility of not having
to  remove  the  pacemaker  device  unnecessarily.  However,  though  there  are  some  reports  of  treatment  only  with
antibiotics,  which  have  been  curative,  most  patients  suffer  an  infective  exacerbation  with  bacteremia,  and  severe
complications necessitating surgical removal of the entire pacing system for cure, as in the second episode of case 1 [2,
3, 8]. This may be the result of biofilm production complicating eradication by antibiotics [9]. In a study investigating
marginal and subgingival plaque formation Cardiobacterium species were shown to be part of the plaques in smokers
[10];  in  case  1  chronic  apical  parodontitis  was  actually  diagnosed  and  three  teeth  removed.  In  another  study,
investigating subgingival biofilms, presence of C. hominis was confirmed and correlated to aggressive periodontitis in
the absence of certain other oral bacteria [11]. Whether a new infection was causing the vegetations in case 1 or it was a
chronic biofilm related infection is unclear.
A  revolution  in  diagnostic  microbiology  has  recently  occurred  with  the  introduction  of  MALDI-ToF  mass
spectrometry [12]. The accuracy, the speed, the relative easy performance protocol and low costs are strong arguments
for its use. HACEK bacteria, including Cardiobacterium strains have been accurately identified to the species level
(>98%) even for very closely related species [13]. The MS identification was also very presumptive for our strains
though  not  conclusive.  In  a  study  on  11  Cardiobacterium  strains  of  which  4  belonged  to  C.  hominis  and  7  to  C.
valvarum, short (526 bp) and near full-length (1399 bp) 16S rRNA gene sequence analysis convincingly allocated the
strains to either C. hominis or C. valvarum [14]. Phylogenetic trees based on 16S rRNA gene sequence analysis clearly
divided the examined strains into the two species.  Thus,  in our case as well  MALDI-ToF MS and 16S rRNA gene
sequence analysis supported the concluded identifications.
Cardiobacterium strains are sensitive to penicillin and most other beta-lactams, in addition to aminoglycosides and
quinolones [3, 4], as also seen for the strain examined in this case report. According to the latest Guidelines on the
prevention, diagnosis, and treatment of infective endocarditis (new version 2009) [15] treatment of non-beta-lactamase
producing HACEK infective endocarditis cases, intravenous ampicillin/penicillin plus gentamicin for 4 weeks is an
option.
CONCLUSION
The present cases illustrate the diversity in disease severity by Cardiobacterium species. Though, PM devices were
present, no definite device related vegetations were recognized. Therefore removal of the devices was avoided and the
patients  were  successfully  treated  with  relevant  antibiotics.  It  stresses  the  importance  of  careful  echocardiographic
examinations when deciding treatment strategy. However, in the C. hominis case a relapse/reinfection episode with C.
hominis occurred two years later with a vegetation present on the PM lead and the PM device and lead was removed.
Long lasting careful follow up has to be performed in order not to overlook a relatively silent relapsing infection.
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